Arizona State Retirement System Macrogenics Inc Transaction History

Arizona State Retirement System

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$3.31 - $18.51 $1,155 - $6,459	349 Added 2.73%	13,134 $55,000
Q1 2024 May 07, 2024	BUY	$9.77 - $21.47 $124,909 - $274,493	12,785 New	12,785 $188,000
Q3 2022 Nov 07, 2022	BUY	$3.01 - $5.22 $96 - $167	32 Added 0.3%	10,834 $37,000
Q2 2022 Jul 28, 2022	SELL	$2.25 - $9.99 $5,501 - $24,425	-2,445 Reduced 18.46%	10,802 $32,000
Q1 2022 May 04, 2022	BUY	$8.12 - $16.9 $730 - $1,520	90 Added 0.68%	13,247 $117,000
Q4 2021 Feb 04, 2022	BUY	$15.91 - $21.88 $1,177 - $1,619	74 Added 0.57%	13,157 $211,000
Q3 2021 Nov 12, 2021	BUY	$19.74 - $28.7 $16,759 - $24,366	849 Added 6.94%	13,083 $274,000
Q2 2021 Aug 02, 2021	SELL	$20.49 - $35.63 $67,801 - $117,899	-3,309 Reduced 21.29%	12,234 $329,000
Q1 2021 May 06, 2021	BUY	$18.99 - $33.2 $12,039 - $21,048	634 Added 4.25%	15,543 $495,000
Q4 2020 Jan 28, 2021	BUY	$19.41 - $26.0 $15,974 - $21,398	823 Added 5.84%	14,909 $341,000
Q3 2020 Nov 05, 2020	BUY	$24.69 - $31.6 $88,464 - $113,222	3,583 Added 34.11%	14,086 $355,000
Q2 2020 Aug 04, 2020	SELL	$5.2 - $29.12 $2,116 - $11,851	-407 Reduced 3.73%	10,503 $293,000
Q1 2020 May 05, 2020	BUY	$4.28 - $12.11 $46,694 - $132,120	10,910 New	10,910 $63,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.